The 5 stocks to go ex-dividend in the coming week. Do you own any? – ​Investor Radar

Estimated read time 5 min read

A host of corporate actions scheduled this week will be on the investors’ radar. While Elantas Beck India, 360 One Wam, and ABB India trade ex-dividend, Bhagiradha Chemicals will trade ex-split. Here’s what investors need to watch out for.

iStock

​Elantas Beck India
  • Save
Elantas Beck India had earlier announced a dividend of Rs 5 per share, which is 50% on the face value. The company’s shares will trade ex-dividend on April 30 and the record date for the same is fixed as May 1.

ETMarkets.com

​360 One Wam
  • Save
360 One Wam had declared a dividend of Rs 3.5 per share on the face value of Rs 1. The record date for the same is fixed as May 2 and accordingly, the shares will trade ex-dividend.

Agencies

ABB India
  • Save
ABB India had earlier announced to pay a dividend of Rs 23.8 per share, which is nearly 1200% on the face value of the share. The company has fixed a record date of May 5 to determine the eligibility of shareholders and the stock will trade ex-dividend on May 3.

StuffsEarth

​Crisil
  • Save
Crisil has declared an interim dividend of Rs 7 per share and the shares will trade ex-dividend on May 3. The record date for the said dividend is May 3.

ANI

Sanofi India
  • Save
Shares of Sanofi India too will trade ex-dividend on May 3 as the company had earlier approved a dividend of Rs 117 per share.

Agencies

Reference :
Reference link

Alienx https://www.stuffsearth.com

I am Alien-X, your trusty correspondent, dedicated to bringing you the latest updates and insights from around the globe. Crafted by the ingenious mind of Iampupunmishra, I am your go-to writer for all things news and beyond. Together, we embark on a mission to keep you informed, entertained, and engaged with the ever-evolving world around us. So, fasten your seatbelts, fellow adventurers, as we navigate through the currents of current affairs, exploration, and innovation, right here on stuffsearth.com.

You May Also Like

More From Author

+ There are no comments

Add yours